logo

For the Inventor, By the Inventor

Reigate, United Kingdom

Richard A Smith

This inventor holds 12 USPTO granted patents. Top assignee: Beecham Group Plc. Active years: 1981-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard A Smith. Retrieved from https://idiyas.com/inventor/richard-a-smith-wax7ep62

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12

% Patents Active = 100.0

Average Co-Inventor Count = 1.4

ph-index = 8

Forward Citations = 123(Granted Patents)


Location History:

  • Wallington, GB (1981)
  • Reigate, GB (1985 - 1988)
  • Reigate Surrey, GB (1986 - 1988)
  • Dorking, GB (1981 - 1989)
  • Epsom, GB (1994)

Company Filing History:

goldMedal12 out of 855 
 
Beecham Group Plc
 patents

Years Active: 1981-1994

Loading Chart...
12 patents (USPTO):Explore Patents
1. 5334384 - Process for purification of streptakinase using a reducing agent (1994-08-02),
2. 5302390 - Hybrid proteins of human plasminogen and human t-PA, pharmaceutical (1994-04-12),
3. 4808405 - P-anisoyl streptokinase/plasminogen complex (1989-02-28),
4. 4741903 - Novel enzyne derivatives (1988-05-03),
5. 4730050 - Novel enzyme derivatives (1988-03-08),
6. 4673573 - Novel fibrinolytic enzyme compounds (1987-06-16),
7. 4604285 - Protein C enzyme derivatives (1986-08-05),
8. 4600580 - Novel enzyme derivatives (1986-07-15),
9. 4507283 - Pharmacologically active compounds (1985-03-26),
10. 4337244 - Enzyme derivatives for use in the treatment of venous thrombosis (1982-06-29),
11. 4285932 - Enzyme derivatives for use in the treatment of venous thrombosis (1981-08-25),
12. 4267273 - Enzyme preparation having affinity for water-immiscible liquids (1981-05-12),

Title: The Innovative Contributions of Richard A Smith

Introduction

Richard A Smith is a notable inventor based in Reigate, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes and hybrid proteins that enhance medical treatments. With a total of 12 patents to his name, Smith's work has had a profound impact on the industry.

Latest Patents

Among his latest patents is a process for the purification of streptokinase using a reducing agent. This innovative method involves treating a streptokinase-containing mixture with a reducing agent to reduce disulphide bridges in contaminating proteins, allowing for the separation of streptokinase in a form that is substantially free of these proteins. Another significant patent is for hybrid proteins of human plasminogen and human t-PA. This hybrid plasminogen activator comprises the five kringle domains of plasminogen linked to the B-chain of t-PA or u-PA, showcasing Smith's expertise in creating advanced pharmaceutical solutions.

Career Highlights

Richard A Smith is currently associated with Beecham Group Plc, where he continues to innovate and contribute to the field of pharmaceuticals. His work has not only advanced medical science but has also paved the way for new treatment methodologies.

Collaborations

Smith has collaborated with notable colleagues such as Harry Ferres and Andrew J Garman, further enhancing the scope and impact of his inventions.

Conclusion

Richard A Smith's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence medical advancements and improve patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…